Literature DB >> 15991046

In vivo detection of metabolic changes by 1H-MRS in the DEN-induced hepatocellular carcinoma in Wistar rat.

Wei-Dong Zhao1, Sheng Guan, Kang-Rong Zhou, Hui Li, Wei-Jun Peng, Feng Tang, Zhong-Wei Chen.   

Abstract

PURPOSE: To investigate the serial changes of the hepatic metabolites in a chemical-induced rat model of hepatocellular carcinoma (HCC) in vivo by a clinical 1.5 T MR scanner.
METHODS: Diethyl nitrosamine (DEN) induced HCC model rats (n=60) and control rats (n=20) were included. From week 7 to week 20 after DEN administration, every other week 10-12 animals (8-9 treated and 2-3 controls) were randomly scanned before being sacrificed. According to the pathologic changes, the whole process of tumorigenesis was divided into early and late periods (week 7-13 and week 14-20, respectively). The serial hepatic changes were tested by both routine MRI and single voxel 1H-MRS and compared with pathological results. Point resolved spectroscopy sequence (PRESS) was used for the location in MRS. The integrations of lipid- and choline-containing metabolites were calculated and analyzed.
RESULTS: All of the listed tests were fully finished in 66 rats (48 treated and 18 controls). Of the MRS curves, 65.2% (43/66) could be analyzed (mainly with resistant baseline with peaks appearing at right positions). From those qualified MRS curves, there were up to seven peaks which could be identified. The peaks of methylene lipids and methyl lipids were combined together in most cases and became the most notable component. The relative integrals of the combined lipid peak and that of the choline-containing compounds in different groups and stages were measured. Comparing with that of the controls of the same stage, the lipid of treated rats decreased in the late stage, and the choline-containing compounds increased in the same stage. Statistically significant differences were found (P<0.05) for the integrals of the lipid and the choline-containing metabolites between treated and controls in the late stage.
CONCLUSIONS: Our initial studies for the integrals of the lipid compounds and the choline-containing metabolites might be useful for a better understanding of the metabolic activity of this DEN-induced rat HCC model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15991046     DOI: 10.1007/s00432-005-0684-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.

Authors:  S G Cho; M Y Kim; H J Kim; Y S Kim; W Choi; S H Shin; K C Hong; Y B Kim; J H Lee; C H Suh
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

2.  The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.

Authors:  W G Cance; A K Stewart; H R Menck
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

3.  The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C.

Authors:  Adrian K P Lim; Nayna Patel; Gavin Hamilton; Joseph V Hajnal; Robert D Goldin; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

4.  Motion correction and lipid suppression for 1H magnetic resonance spectroscopy.

Authors:  J M Star-Lack; E Adalsteinsson; G E Gold; D M Ikeda; D M Spielman
Journal:  Magn Reson Med       Date:  2000-03       Impact factor: 4.668

5.  MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer.

Authors:  Masaru Hasumi; Kazuhiro Suzuki; Nariyuki Oya; Kazuto Ito; Kohei Kurokawa; Yoshitatsu Fukabori; Hidetoshi Yamanaka
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

6.  Regulation of PUFA metabolism: pharmacological and toxicological aspects.

Authors:  P Risé; F Marangoni; C Galli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Aug-Sep       Impact factor: 4.006

Review 7.  NMR studies of phospholipid metabolism in hepatic lymphoma.

Authors:  R M Dixon
Journal:  NMR Biomed       Date:  1998-11       Impact factor: 4.044

8.  (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.

Authors:  Marrita M Mahon; I Jane Cox; Roberto Dina; W Patrick Soutter; G Angus McIndoe; Andreanna D Williams; Nandita M deSouza
Journal:  J Magn Reson Imaging       Date:  2004-03       Impact factor: 4.813

9.  Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques.

Authors:  A K P Lim; N Patel; W M W Gedroyc; M J K Blomley; G Hamilton; S D Taylor-Robinson
Journal:  Br J Radiol       Date:  2002-08       Impact factor: 3.039

10.  In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver.

Authors:  S D Taylor-Robinson; J Sargentoni; J D Bell; N Saeed; K K Changani; B R Davidson; K Rolles; A K Burroughs; H J Hodgson; C S Foster; I J Cox
Journal:  Liver       Date:  1997-08
View more
  7 in total

1.  Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy.

Authors:  Susanne Bonekamp; Jialin Shen; Nouha Salibi; Hong C Lai; Jeff Geschwind; Ihab R Kamel
Journal:  J Comput Assist Tomogr       Date:  2011 Mar-Apr       Impact factor: 1.826

2.  Quantification of choline concentration following liver cell apoptosis using 1H magnetic resonance spectroscopy.

Authors:  Zhi-Wei Shen; Zhen Cao; Ke-Zeng You; Zhong-Xian Yang; Ye-Yu Xiao; Xiao-Fang Cheng; Yao-Wen Chen; Ren-Hua Wu
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

3.  Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin.

Authors:  Chunyun Pu; Shaorong Tian; Sanxiu He; Weihong Chen; Yuanyuan He; Hongyan Ren; Jing Zhu; Jun Tang; Xiaolan Huang; Ying Xiang; Yixiao Fu; Tingxiu Xiang
Journal:  Genes Dis       Date:  2020-12-02

4.  Comprehensive small animal imaging strategies on a clinical 3 T dedicated head MR-scanner; adapted methods and sequence protocols in CNS pathologies.

Authors:  Deepu R Pillai; Robin M Heidemann; Praveen Kumar; Nagesh Shanbhag; Titus Lanz; Michael S Dittmar; Beatrice Sandner; Christoph P Beier; Norbert Weidner; Mark W Greenlee; Gerhard Schuierer; Ulrich Bogdahn; Felix Schlachetzki
Journal:  PLoS One       Date:  2011-02-07       Impact factor: 3.240

5.  Application of Single Voxel 1H Magnetic Resonance Spectroscopy in Hepatic Benign and Malignant Lesions.

Authors:  Zifeng Yang; Shiqiang Sun; Yuanli Chen; Rui Li
Journal:  Med Sci Monit       Date:  2016-12-19

6.  Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic study.

Authors:  Yang Chen; Jianyin Zhou; Jinquan Li; Jianghua Feng; Zhong Chen; Xiaomin Wang
Journal:  Oncotarget       Date:  2016-07-26

7.  Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via 1H NMR-Based Metabolomic Analysis.

Authors:  Minjiang Chen; Siming Lu; Hong Zheng; Min Xu; Jingjing Song; Weibin Yang; Qiaoyou Weng; Liyun Zheng; Xiaoxi Fan; Xingyao Cheng; Hongchang Gao; Jiansong Ji
Journal:  Biomed Res Int       Date:  2019-01-02       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.